Central nervous system (CNS) 
Introduction
Sarcoidosis is a systemic granulomatous disease of unknown etiology (1) (2) (3) (4) . The symptoms depend on the location of affected lesions and the severity of the dysfunction. The incidence is 6 out of 100,000 persons in a year, and affects mainly objects in 20s to 40s (1) . About 5% of patients with sarcoidosis have central nervous system (CNS) sarcoidosis (5, 6) (3, 7, 8) .
. Polyuria and polydipsia are common presenting features of hypothalamic involvement, due either to hypothalamic diabetes insipidus or disordered control of thirst. Central diabetes insipidus (CDI) due to dysfunction of hypothalamus is one of the clinical manifestations in CNS sarcoidosis (5, 6). Seventy percent of cases with non-CNS sarcoidosis spontaneously recover, whereas most of CNS sarcoidosis, critical organ dysfunction, or hypercalcemia require steroid treatments or advanced immunosuppressive therapy
In CNS sarcoidosis, the delay of initial treatment of steroid easily leads to the irreversible CDI (9, 10) . Thus the prompt diagnosis is important.
Although the prognosis of CNS sarcoidosis with/without steroid treatments is poor (9, 10) (Fig. 4) (Fig. 4) (11) . The incidence of sarcoidosis is 6 out of 100,000 persons, and CDI is 1 out of 25,000 persons (1, 12) , indicating the case of incidental development of both disorder is rare. In the cases of CDI due to sarcoidosis, the severity of pulmonary lesion tends to be mild (7) . Taken together, although we have not performed pituitary biopsy, we considered that her CDI was due to CNS sarcoidosis.
observed in bone lesions (figure not shown). Tracer; [F-18]-2-fluoro-2-deoxy-D-glucose (FDG) accumulations in bilateral hilar lymph nodes and right gluteal cutaneous nodule were observed in positron emission tomography (PET) scintigram (Fig. 2). Accumulation in pituitary was obscure. Subsequently, the biopsy of the right gluteal cutaneous nodule was performed. Noncaseating epithelioid granulomas were found in the specimen. The epithelioid histiocytes and absence of necrosis were notable (Fig. 3). With exception of similar granulomatous diseases such as Wegener granulomatosis, and the diagnosis was done as sarcoidosis, although other diseases including lymphocytic hypophysitis were not completely ruled out the possibility.

F i g u r e 3 . T i s s u e o b t a i n e d f r o m r i g h t g l u t e a l c u t a n e o u s n o du l e ( × 1 0 0 ) ( He ma t o x y l i n a n d E o s i n s t a i n i n g ) . No n c a s e a t i n g e p i t h e l i o i d g r a n u l o ma a n d L a n g h a n s ' -t y p e g i a n t c e l l ( a r r o w) we r e f o u n d i n t h e s p e c i me n . I n f l a mma t o r y c e l l s we r e a l s o o b s e r v e d .
F i g u r e 4 . Cl i n i c a l c o u r s e . On a d mi s s i o n , d a i l y a mo u n t s o f DDAVP wa s 5 μ g / d a y t o k e e p u r i n e v o l u me o f 1 5 0 0 -3 0 0 0 mL / d a y , wh e r e a s t wo we e k s a f t e r a d mi s s i o n , t h e r e q u i r e d a mo u n t s o f DDAVP wa s d e c r e a s e d t o 2 . 5 μ g / d a y , mo r e o v e r 1 6 we e k s l a t e r , t h e a mo u n t o f DDAVP wa s a p p r o x ima t e l y 0 . 3 μ g / d a y . S o o n a f t e r t h a t , DDAVP t r e a t me n t wa s t e r mi n a t e d .
Clinical Course
The steroid therapy is a major treatment for CNS sarcoidosis (1, 5, 6 It is reported that CNS sarcoidosis progressively deteriorates and has a poor prognosis (7) . In a literature of CDI due to sarcoidosis (10) 
